These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26786660)

  • 1. Novel mutations conferring resistance to kanamycin in Mycobacterium tuberculosis clinical isolates from Northern India.
    Kaur S; Rana V; Singh P; Trivedi G; Anand S; Kaur A; Gupta P; Jain A; Sharma C
    Tuberculosis (Edinb); 2016 Jan; 96():96-101. PubMed ID: 26786660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables.
    Kambli P; Ajbani K; Nikam C; Sadani M; Shetty A; Udwadia Z; Georghiou SB; Rodwell TC; Catanzaro A; Rodrigues C
    Int J Mycobacteriol; 2016 Mar; 5(1):1-6. PubMed ID: 26927983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of
    Bablishvili N; Tukvadze N; Shashkina E; Mathema B; Gandhi NR; Blumberg HM; Kempker RR
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of eis mutations in the development of kanamycin resistance in Mycobacterium tuberculosis isolates from the Moscow region.
    Gikalo MB; Nosova EY; Krylova LY; Moroz AM
    J Antimicrob Chemother; 2012 Sep; 67(9):2107-9. PubMed ID: 22593564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs.
    Said HM; Kock MM; Ismail NA; Baba K; Omar SV; Osman AG; Hoosen AA; Ehlers MM
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):104-9. PubMed ID: 22236854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoglycoside cross-resistance in Mycobacterium tuberculosis due to mutations in the 5' untranslated region of whiB7.
    Reeves AZ; Campbell PJ; Sultana R; Malik S; Murray M; Plikaytis BB; Shinnick TM; Posey JE
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1857-65. PubMed ID: 23380727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.
    Jnawali HN; Hwang SC; Park YK; Kim H; Lee YS; Chung GT; Choe KH; Ryoo S
    Diagn Microbiol Infect Dis; 2013 Jun; 76(2):187-96. PubMed ID: 23561273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redefining MDR-TB: Comparison of Mycobacterium tuberculosis clinical isolates from Russia and Taiwan.
    Jou R; Lee WT; Kulagina EV; Weng JY; Isakova AI; Lin WH; Antonova OV; Wu MH; Arslanbaeva LR; Tasi HY; Nosova EY; Zimenkov DV
    Infect Genet Evol; 2019 Aug; 72():141-146. PubMed ID: 30593924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA expression analysis of efflux pump genes in clinical isolates of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in South Korea.
    Oh TS; Kim YJ; Kang HY; Kim CK; Cho SY; Lee HJ
    Infect Genet Evol; 2017 Apr; 49():111-115. PubMed ID: 28062386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid molecular screening for multidrug-resistant tuberculosis in a resource-limited region of China.
    Zhang D; Liu B; Wang Y; Pang Y
    Trop Med Int Health; 2014 Oct; 19(10):1259-66. PubMed ID: 25040060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of mutations conferring streptomycin resistance to multidrug-resistant Mycobacterium tuberculosis isolates from Myanmar.
    Thida Oo NA; San LL; Thapa J; Aye KS; Aung WW; Nakajima C; Suzuki Y
    Tuberculosis (Edinb); 2018 Jul; 111():8-13. PubMed ID: 30029920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of eis without a mutation in promoter region of amikacin- and kanamycin-resistant Mycobacterium tuberculosis clinical strain.
    Sowajassatakul A; Prammananan T; Chaiprasert A; Phunpruch S
    Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):33. PubMed ID: 30008266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review.
    Georghiou SB; Magana M; Garfein RS; Catanzaro DG; Catanzaro A; Rodwell TC
    PLoS One; 2012; 7(3):e33275. PubMed ID: 22479378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis.
    Engström A; Perskvist N; Werngren J; Hoffner SE; Juréen P
    J Antimicrob Chemother; 2011 Jun; 66(6):1247-54. PubMed ID: 21427106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applied multiplex allele specific PCR to detect second-line drug resistance among multidrug-resistant tuberculosis in China.
    Liang YP; Chen Y; Xiao TY; Xia Q; Liu HC; Zhao XQ; Zeng CY; Zhao LL; Wan KL
    Tuberculosis (Edinb); 2017 Dec; 107():1-4. PubMed ID: 29050755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis.
    Zaunbrecher MA; Sikes RD; Metchock B; Shinnick TM; Posey JE
    Proc Natl Acad Sci U S A; 2009 Nov; 106(47):20004-9. PubMed ID: 19906990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance comparison of four methods for detecting multidrug-resistant Mycobacterium tuberculosis strains.
    Al-Mutairi NM; Ahmad S; Mokaddas E
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):110-5. PubMed ID: 21276306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Investigation of Resistance to Second-Line Injectable Drugs in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis in France.
    Brossier F; Pham A; Bernard C; Aubry A; Jarlier V; Veziris N; Sougakoff W;
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrazinamide resistance in Mycobacterium tuberculosis arises after rifampicin and fluoroquinolone resistance.
    Alame-Emane AK; Xu P; Pierre-Audigier C; Cadet-Daniel V; Shen X; Sraouia M; Siawaya JF; Takiff H; Gao Q; Gicquel B
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):679-84. PubMed ID: 25946359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of pncA mutations in drug-resistant Mycobacterium tuberculosis isolated from patients in South Korea.
    Kim HJ; Kwak HK; Lee J; Yun YJ; Lee JS; Lee MS; Min SY; Park SK; Kang HS; Maeng YH; Kim SY; Kim SY; Kook YH; Kim YR; Lee KH
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):98-103. PubMed ID: 22236853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.